Kevin R Sayer Dexcom Inc (DXCM) insider trading activity

DXCM Quotes by TradingView

Kevin R Sayer is President CEO and Chairman of DEXCOM INC. Currently has a direct ownership of 283,893 shares of DXCM, which is worth approximately $22.8 Million. The most recent transaction as insider was on Apr 08, 2024, when has been sold 49,633 shares (Common Stock) at a price of $138.34 per share, resulting in proceeds of $6,866,229. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 284K
0% 3M change
13.3% 12M change
Total Value Held $22.8 Million

KEVIN R SAYER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 08 2024
SELL
Open market or private sale
$6,866,229 $138.34 p/Share
49,633 Reduced 14.88%
283,893 Common Stock
Mar 12 2024
SELL
Open market or private sale
$10,789,322 $133.19 p/Share
81,007 Reduced 19.54%
333,526 Common Stock
Mar 08 2024
BUY
Grant, award, or other acquisition
-
51,692 Added 11.09%
414,533 Common Stock
Jan 16 2024
SELL
Open market or private sale
$4,614,489 $123.63 p/Share
37,325 Reduced 9.33%
362,841 Common Stock
Jan 12 2024
BUY
Grant, award, or other acquisition
-
72,709 Added 15.38%
400,166 Common Stock
Apr 03 2023
SELL
Open market or private sale
$2,385,887 $114.64 p/Share
20,812 Reduced 5.98%
327,457 Common Stock
Mar 10 2023
SELL
Sale (or disposition) back to the issuer
$4,176,386 $111.4 p/Share
37,490 Reduced 9.72%
348,269 Common Stock
Mar 08 2023
BUY
Grant, award, or other acquisition
-
54,422 Added 12.36%
385,759 Common Stock
Mar 01 2023
SELL
Open market or private sale
$4,235,655 $110.12 p/Share
38,464 Reduced 10.4%
331,337 Common Stock
Jan 30 2023
SELL
Open market or private sale
$6,045,927 $106.36 p/Share
56,844 Reduced 13.32%
369,801 Common Stock
Jan 20 2023
SELL
Open market or private sale
$4,822,940 $105.75 p/Share
45,607 Reduced 9.66%
426,645 Common Stock
Jan 18 2023
BUY
Grant, award, or other acquisition
-
90,720 Added 16.11%
472,252 Common Stock
Nov 03 2022
SELL
Bona fide gift
-
10,000 Reduced 2.55%
381,532 Common Stock
Mar 15 2022
SELL
Open market or private sale
$1,232,340 $410.78 p/Share
3,000 Reduced 2.97%
97,883 Common Stock
Mar 09 2022
SELL
Sale (or disposition) back to the issuer
$4,054,509 $406.06 p/Share
9,985 Reduced 9.01%
100,883 Common Stock
Mar 08 2022
BUY
Grant, award, or other acquisition
-
16,251 Added 12.78%
110,868 Common Stock
Feb 14 2022
SELL
Open market or private sale
$1,254,120 $418.04 p/Share
3,000 Reduced 3.07%
94,617 Common Stock
Jan 18 2022
SELL
Open market or private sale
$9,906,951 $436.93 p/Share
22,674 Reduced 18.85%
97,617 Common Stock
Jan 18 2022
BUY
Grant, award, or other acquisition
-
38,586 Added 24.75%
117,291 Common Stock
Dec 15 2021
SELL
Open market or private sale
$1,608,450 $536.15 p/Share
3,000 Reduced 3.54%
81,705 Common Stock
Nov 15 2021
SELL
Open market or private sale
$1,945,500 $648.5 p/Share
3,000 Reduced 3.42%
84,705 Common Stock
Nov 12 2021
SELL
Bona fide gift
-
3,000 Reduced 3.31%
87,705 Common Stock
Oct 15 2021
SELL
Open market or private sale
$3,302,340 $550.39 p/Share
6,000 Reduced 6.2%
90,705 Common Stock
Sep 15 2021
SELL
Open market or private sale
$3,241,680 $540.28 p/Share
6,000 Reduced 5.84%
96,705 Common Stock
Sep 09 2021
SELL
Open market or private sale
$1,633,162 $541.32 p/Share
3,017 Reduced 2.85%
102,705 Common Stock
KRS

Kevin R Sayer

President CEO and Chairman
San Diego, CA

Track Institutional and Insider Activities on DXCM

Follow DEXCOM INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DXCM shares.

Notify only if

Insider Trading

Get notified when an Dexcom Inc insider buys or sells DXCM shares.

Notify only if

News

Receive news related to DEXCOM INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DXCM